购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

BX-912

Rating icon 很棒
产品编号 T1837Cas号 702674-56-4

BX-912 是一种直接的,选择性的,ATP 竞争性的PDK1抑制剂,IC50值为 26 nM。它阻断肿瘤细胞 PDK1/Akt 信号转导,抑制多种肿瘤细胞株的锚定依赖性生长或诱导凋亡。

BX-912
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

BX-912

Rating icon 很棒
纯度: 99.34%
产品编号 T1837Cas号 702674-56-4

BX-912 是一种直接的,选择性的,ATP 竞争性的PDK1抑制剂,IC50值为 26 nM。它阻断肿瘤细胞 PDK1/Akt 信号转导,抑制多种肿瘤细胞株的锚定依赖性生长或诱导凋亡。

规格价格库存数量
1 mg¥ 419现货
2 mg¥ 597现货
5 mg¥ 788现货
10 mg¥ 1,330现货
25 mg¥ 2,660现货
50 mg¥ 3,930现货
100 mg¥ 5,730现货
1 mL x 10 mM (in DMSO)¥ 818现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"BX-912"的相关化合物库

选择批次:
纯度:99.34%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
BX-912 is a specific inhibitor of 3-Phosphoinositide-dependent Kinase-1 (PDK1, IC50: 12 nM). The selectivity of BX-912 is more 10 fold than C-Kit, EGFR, PKA, PKC etc.
靶点活性
PDK1:12 nM
体外活性
BX-912对ChcK1(IC50:0.83 μM),PKA(IC50:0.11 μM),c-kit(IC50:0.85 μM)和KDR(IC50:0.41 μM)有抑制作用。在肿瘤细胞中,BX-912可阻断PDK1/Akt信号,能抑制多种肿瘤细胞的贴壁依赖型生长(比如PC-3细胞)或者诱导凋亡。许多Akt活性升高的癌细胞株在软琼脂中对BX-912引起的生长抑制的敏感性比在组织培养塑料中高30倍,与PDK1/Akt信号通路的细胞生存功能一致,这对未贴壁细胞尤为重要。BX-912对PDK1酶活有显著的抑制效果, 但不影响AKT2活性(IC50>10 μM),故BX-912是PDK1的直接抑制剂。BX-912使含4 NDNA的MDA-468细胞数显著增多,并使细胞停在G2/M期。BX-912有效抑制细胞生长(IC50:0.32 μM)。BX-912(1 μM)对HCT-116细胞生长的抑制也十分有效(抑制率达96%)。
激酶实验
Kinase assays: PDK1 is assayed in a direct kinase assay and a coupled assay format measuring PDK1- and PtdIns-3,4-P2-mediated activation of AKT2. For the coupled assay, the final assay mixture (60 μL) contained: 15 mM MOPS, pH 7.2, 1 mg/mL bovine serum albumin, 18 mM β-glycerol phosphate, 0.7 mM dithiothreitol, 3 mM EGTA, 10 mM MgOAc, 7.5 μM ATP, 0.2 μCi of [γ- 33P]ATP, 7.5 μM biotinylated peptide substrate (biotin-ARRRDGGGAQPFRPRAATF), 0.5 μL of PtdIns-3,4-P2-containing phospholipid vesicles, 60 pg of purified recombinant human PDK1, and 172 ng of purified recombinant human AKT2. After incubation for 2 hours at room temperature, the biotin-labeled peptide is captured from 10 μL of the assay mixture on streptavidin-coated SPA beads, and product formation is measured by scintillation proximity in a Wallac MicroBeta counter. The product formed is proportional to the time of incubation and to the amount of PDK1 and inactive AKT2 added. PDK1 is added at suboptimal levels so that the assay could sensitively detect inhibitors of AKT2 activation as well as direct inhibitor BX912 of PDK1 or AKT2. To measure PDK1 activity directly, the final assay mixture (60 μL) contained 50 mM Tris-HCl, pH 7.5, 0.1 mM EGTA, 0.1 mM EDTA, 0.1% β-mercaptoethanol, 1 mg/mL bovine serum albumin, 10 mM MgOAc, 10 μM ATP, 0.2 μCi of [γ-33P]ATP, 7.5 μM substrate peptide (H2N-ARRRGVTTKTFCGT), and 60 ng of purified recombinant human PDK1. After 4 hours at room temperature, 25 mM EDTA is added and a portion of the reaction mixture on P81 phosphocellulose paper is spotted. The filter paper is washed three times with 0.75% phosphoric acid and once with acetone. After drying, the filter-bound labeled peptide is quantified using a phosphorimager.
细胞实验
Cells such as MDA-468, MDA-453 are seeded at a low density (1.5-3 × 103 cells/well, 0.1 mL/well, 96-well plates) and are incubated overnight. BX912 treatments are made by adding 10 μL/well of the compound in 1% dimethyl sulfoxide and growth medium (final concentration of dimethyl sulfoxide, 0.1%), followed by brief shaking. Treated cells are incubated for 72 hours, and viability is measured by the addition of 10 μL of the metabolic dye WST-1. The WST-1 signal is read in a plate reader at 450 nm, and a no cell, or zero time cell, background is subtracted to calculate the net signal. (Only for Reference)
化学信息
分子量471.35
分子式C20H23BrN8O
CAS No.702674-56-4
SmilesBrc1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCc1cnc[nH]1
密度1.596
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 87 mg/mL (184.6 mM)
Ethanol: 87 mg/mL (184.6 mM)
溶液配制表
1mg5mg10mg50mg
1 mM2.1216 mL10.6078 mL21.2157 mL106.0783 mL
5 mM0.4243 mL2.1216 mL4.2431 mL21.2157 mL
10 mM0.2122 mL1.0608 mL2.1216 mL10.6078 mL
20 mM0.1061 mL0.5304 mL1.0608 mL5.3039 mL
50 mM0.0424 mL0.2122 mL0.4243 mL2.1216 mL
100 mM0.0212 mL0.1061 mL0.2122 mL1.0608 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy BX-912 | purchase BX-912 | BX-912 cost | order BX-912 | BX-912 chemical structure | BX-912 in vitro | BX-912 formula | BX-912 molecular weight